Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 20, Number 5—May 2014

Research

Persistence and Complex Evolution of Fluoroquinolone-Resistant Streptococcus pneumoniae Clone

Debby Ben-DavidComments to Author , Mitchell J. Schwaber, Amos Adler, Samira Masarwa, Rotem Edgar, Shiri Navon-Venezia, David Schwartz, Nurith Porat, Tali Kotlovsky, Nikolay Polivkin, Irina Weinberg, Avraham Lazary, Nissim Ohana, and Ron Dagan
Author affiliations: National Center for Infection Control, Tel Aviv, Israel (D. Ben-David, M.J. Schwaber, A. Adler, S. Masarwa, R. Edgar, S. Navon-Venezia); Sourasky Medical Center, Tel Aviv (D. Schwartz, N. Porat, T. Kotlovsky, R. Dagan); Ben-Gurion University of the Negev, Beer-Sheva (N. Porat, R. Dagan); Reuth Medical Center, Tel Aviv (N. Polivkin, I. Weinberg, A. Lazary, N. Ohana)

Main Article

Figure 2

Clinical isolates of FQ-resistant Streptococcus pneumoniae in a post–acute care facility, Israel, 2006–2011. FQ, fluoroquinolone.

Figure 2. Clinical isolates of FQ-resistant Streptococcus pneumoniae in a post–acute care facility, Israel, 2006–2011FQ, fluoroquinolone.

Main Article

TOP